About The Oncology Institute, Inc. 
The Oncology Institute, Inc.
Pharmaceuticals & Biotechnology
DFP Healthcare Acquisitions Corp. is a blank check company. The Company’s business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It focuses on identifying a target business in the healthcare or healthcare-related industries in the United States and other developed countries. The Company focuses its investment effort across the entire healthcare industry, which encompasses services, therapeutics, devices, diagnostics and animal health.
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 6 Schemes (16.52%)
Foreign Institutions
Held by 15 Foreign Institutions (3.06%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
120 Million
(Quarterly Results - Jun 2025)
Net Profit:
-14 Million
Pharmaceuticals & Biotechnology
USD 304 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-5.75
522.19%
-33.82






